Status:
NOT_YET_RECRUITING
Evaluating Urine Isoniazid Testing to Detect Nonadherence to Tuberculosis Medications in India
Lead Sponsor:
Tufts University
Collaborating Sponsors:
Tuberculosis Research Centre, India
Massachusetts General Hospital
Conditions:
Tuberculosis, Pulmonary
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Tuberculosis (TB) is the leading infectious cause of death globally. India has the largest TB epidemic, accounting for one-quarter of cases and one-third of TB deaths worldwide. Nonadherence to medica...
Detailed Description
Tuberculosis (TB) is the leading infectious cause of death globally. India has the largest TB epidemic, accounting for one-quarter of cases and one-third of global TB deaths. Nonadherence to TB medica...
Eligibility Criteria
Inclusion
- 18+ years of age,
- presumed or confirmed drug-susceptible pulmonary TB (with or without a previous TB history), and
- taking an isoniazid-containing TB regimen.
Exclusion
- inability to provide informed consent, or
- drug-resistant TB diagnosis or switch to another non-isoniazid-containing regimen (Note that this second exclusion criteria may result in retrospective exclusion from the study).
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2028
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT06526221
Start Date
April 1 2025
End Date
September 30 2028
Last Update
January 6 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.